A review of thromboembolic events in hospitalized COVID-19 patients

Paul Fontelo, Mrigendra M Bastola, Zhaonian Zheng, Seo Hyon Baik, Paul Fontelo, Mrigendra M Bastola, Zhaonian Zheng, Seo Hyon Baik

Abstract

Context: A higher incidence of thromboembolic disorders in COVID-19 has been reported by many clinicians worldwide.

Objective, design and data sources: Selected studies found in PubMed that reported thromboembolic events were included for meta-analysis using weighted fixed and random effects. Data from 19 articles on cohort studies in patients diagnosed with COVID-19 and thromboembolic events, including thrombosis and embolism were included in this review.

Results: The likelihood for developing thromboembolic disorders in hospitalized COVID-19 patients was 0.28 (95% CI 0.21-0.36).

Conclusion: This study further validates the increased risk of VTE in COVID-19 patients when compared to healthy, non-hospitalized people, and hospitalized patients. These findings will be useful to researchers and medical practitioners caring for COVID-19 patients.

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Flow Diagram of the Search Protocol
Fig. 2
Fig. 2
Forest Plot of the Analysis

References

    1. Smeeth L, Cook C, Thomas S, Hall A, Hubbard R, Vallance P. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet. 2006;367(9516):1075–1079. doi: 10.1016/S0140-6736(06)68474-2.
    1. Cui J, Li F, Shi Z. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2018;17(3):181–192. doi: 10.1038/s41579-018-0118-9.
    1. Li J, You Z, Wang Q, Zhou Z, Qiu Y, Luo R, et al. The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future. Microbes Infect. 2020;22(2):80–85. doi: 10.1016/j.micinf.2020.02.002.
    1. Kahn J, McIntosh K. History and recent advances in coronavirus discovery. Pediatr Infect Dis J. 2005;24(11):S223–S227. doi: 10.1097/01.inf.0000188166.17324.60.
    1. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W, China Novel Coronavirus Investigating and Research Team A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi: 10.1056/NEJMoa2001017.
    1. Middle East respiratory syndrome coronavirus (MERS-CoV) . 2021.
    1. Lee N, Hui D, Wu A, Chan P, Cameron P, Joynt G, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1986–1994. doi: 10.1056/NEJMoa030685.
    1. Singh S. Middle East respiratory syndrome virus pathogenesis. Seminars in Respiratory and Critical Care Medicine. 2016;37(04):572–577. doi: 10.1055/s-0036-1584796.
    1. van den Brand J, Smits S, Haagmans B. Pathogenesis of Middle East respiratory syndrome coronavirus. J Pathol. 2014;235(2):175–184. doi: 10.1002/path.4458.
    1. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect. 2020;9(1):687–690. doi: 10.1080/22221751.2020.1741327.
    1. ArcGIS Dashboards [Internet]. . 2021 [cited 29 March 2021]. Available from:
    1. Petrosillo N, Viceconte G, Ergonul O, Ippolito G, Petersen E. COVID-19, SARS and MERS: are they closely related? Clin Microbiol Infect. 2020;26(6):729–734. doi: 10.1016/j.cmi.2020.03.026.
    1. Jin S, Jin Y, Xu B, Hong J, Yang X. Prevalence and impact of coagulation dysfunction in COVID-19 in China: a meta-analysis. Thromb Haemost. 2020;120(11):1524–1535. doi: 10.1055/s-0040-1714369.
    1. Barnes B, Adrover J, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, Crawford J, et al. Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med. 2020;217(6):e20200652. doi: 10.1084/jem.20200652.
    1. Ackermann M, Verleden S, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular Endothelialitis, thrombosis, and angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–128. doi: 10.1056/NEJMoa2015432.
    1. Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30(5):367–369. doi: 10.1038/s41422-020-0327-4.
    1. Gertz M, Kyle R. Hyperviscosity syndrome. J Intensive Care Med. 1995;10(3):128–141. doi: 10.1177/088506669501000304.
    1. Gupta N, Zhao Y, Evans C. The stimulation of thrombosis by hypoxia. Thromb Res. 2019;181:77–83. doi: 10.1016/j.thromres.2019.07.013.
    1. Oxley T, Mocco J, Majidi S, Kellner C, Shoirah H, Singh I, et al. Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med. 2020;382(20):e60. doi: 10.1056/NEJMc2009787.
    1. Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535. doi: 10.1136/bmj.b2535.
    1. Stoneham S, Milne K, Nuttall E, Frew G, Sturrock B, Sivaloganathan H, et al. Thrombotic risk in COVID-19: a case series and case–control study. Clin Med. 2020;20(4):e76–e81. doi: 10.7861/clinmed.2020-0228.
    1. Zhang L, Feng X, Zhang D, Jiang C, Mei H, Wang J, Zhang C, Li H, Xia X, Kong S, Liao J, Jia H, Pang X, Song Y, Tian Y, Wang B, Wu C, Yuan H, Zhang Y, Li Y, Sun W, Zhang Y, Zhu S, Wang S, Xie Y, Ge S, Zhang L, Hu Y, Xie M. Deep vein thrombosis in hospitalized patients with COVID-19 in Wuhan, China. Circulation. 2020;142(2):114–128. doi: 10.1161/CIRCULATIONAHA.120.046702.
    1. Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421–1424. doi: 10.1111/jth.14830.
    1. Klok F, Kruip M, van der Meer N, Arbous M, Gommers D, Kant K, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb Res. 2020;191:148–150. doi: 10.1016/j.thromres.2020.04.041.
    1. Demelo-Rodríguez P, Cervilla-Muñoz E, Ordieres-Ortega L, Parra-Virto A, Toledano-Macías M, Toledo-Samaniego N, García-García A, García-Fernández-Bravo I, Ji Z, de-Miguel-Diez J, Álvarez-Sala-Walther LA, del-Toro-Cervera J, Galeano-Valle F. Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels. Thromb Res. 2020;192:23–26. doi: 10.1016/j.thromres.2020.05.018.
    1. Pavoni V, Gianesello L, Pazzi M, Stera C, Meconi T, Frigieri F. Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia. J Thromb Thrombolysis. 2020;50(2):281–286. doi: 10.1007/s11239-020-02130-7.
    1. Middeldorp S, Coppens M, van Haaps T, Foppen M, Vlaar A, Müller M. Incidence of venous thromboembolism in hospitalized patients with COVID-19. J Vascular Surg. 2021;9(2):536. doi: 10.1016/j.jvsv.2020.12.004.
    1. Lodigiani C, Iapichino G, Carenzo L, Cecconi M, Ferrazzi P, Sebastian T, Kucher N, Studt JD, Sacco C, Bertuzzi A, Sandri MT, Barco S, Humanitas COVID-19 Task Force Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thrombosis Res. 2020;191:9–14. doi: 10.1016/j.thromres.2020.04.024.
    1. Llitjos J, Leclerc M, Chochois C, Monsallier J, Ramakers M, Auvray M, et al. High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients. J Thromb Haemost. 2020;18(7):1743–1746. doi: 10.1111/jth.14869.
    1. Helms J, Tacquard C, Severac F, Leonard-Lorant I, Ohana M, Delabranche X, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi: 10.1007/s00134-020-06062-x.
    1. Koleilat I, Galen B, Choinski K, Hatch A, Jones D, Billett H, et al. Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019. J Vasc Surg. 2021;9(1):36–46. doi: 10.1016/j.jvsv.2020.06.012.
    1. Zerwes S, Hernandez Cancino F, Liebetrau D, Gosslau Y, Warm T, Märkl B, Hyhlik-Dürr A. Erhöhtes Risiko für tiefe Beinvenenthrombosen bei Intensivpatienten mit CoViD-19-Infektion? – Erste Daten. Chirurg. 2020;91(7):588–594. doi: 10.1007/s00104-020-01222-7.
    1. Thomas W, Varley J, Johnston A, Symington E, Robinson M, Sheares K, Lavinio A, Besser M. Thrombotic complications of patients admitted to intensive care with COVID-19 at a teaching hospital in the United Kingdom. Thromb Res. 2020;191:76–77. doi: 10.1016/j.thromres.2020.04.028.
    1. Nahum J, Morichau-Beauchant T, Daviaud F, Echegut P, Fichet J, Maillet J, et al. Venous thrombosis among critically ill patients with coronavirus disease 2019 (COVID-19) JAMA Netw Open. 2020;3(5):e2010478. doi: 10.1001/jamanetworkopen.2020.10478.
    1. Longchamp A, Longchamp J, Manzocchi-Besson S, Whiting L, Haller C, Jeanneret S, Godio M, Garcia Martinez JJ, Bonjour T, Caillat M, Maitre G, Thaler JM, Pantet R, Donner V, Dumoulin A, Emonet S, Greub G, Friolet R, Robert-Ebadi H, Righini M, Sanchez B, Delaloye J. Venous thromboembolism in critically ill patients with COVID-19: results of a screening study for deep vein thrombosis. Res Pract Thrombosis Haemostasis. 2020;4(5):842–847. doi: 10.1002/rth2.12376.
    1. Gervaise A, Bouzad C, Peroux E, Helissey C. Acute pulmonary embolism in non-hospitalized COVID-19 patients referred to CTPA by emergency department. Eur Radiol. 2020;30(11):6170–6177. doi: 10.1007/s00330-020-06977-5.
    1. Mestre-Gómez B, Lorente-Ramos R, Rogado J, Franco-Moreno A, Obispo B, Salazar-Chiriboga D, et al. Incidence of pulmonary embolism in non-critically ill COVID-19 patients. Predicting factors for a challenging diagnosis. J Thromb Thrombolysis. 2020;51(1):40–46. doi: 10.1007/s11239-020-02190-9.
    1. Inciardi R, Adamo M, Lupi L, Cani D, Di Pasquale M, Tomasoni D, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in northern Italy. Eur Heart J. 2020;41(19):1821–1829. doi: 10.1093/eurheartj/ehaa388.
    1. Soumagne T, Lascarrou J, Hraiech S, Horlait G, Higny J, d’Hondt A, et al. Factors associated with pulmonary embolism among coronavirus disease 2019 acute respiratory distress syndrome: a multicenter study among 375 patients. Crit Care Explor. 2020;2(7):e0166. doi: 10.1097/CCE.0000000000000166.
    1. Freeman M, Tukey J. Transformations related to the angular and the square root. Ann Math Stat. 1950;21(4):607–611. doi: 10.1214/aoms/1177729756.
    1. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2.
    1. Jackson D. Confidence intervals for the between-study variance in random effects meta-analysis using generalised Cochran heterogeneity statistics. Res Synth Methods. 2013;4(3):220–229. doi: 10.1002/jrsm.1081.
    1. Sedgwick P. Meta-analyses: how to read a funnel plot. BMJ. 2013;346(mar01 2):f1342. doi: 10.1136/bmj.f1342.
    1. Zhang L, Gerson L, Maluf-Filho F. Systematic review and meta-analysis in GI endoscopy: why do we need them? How can we read them? Should we trust them? Gastrointest Endosc. 2018;88(1):139–150. doi: 10.1016/j.gie.2018.03.001.
    1. Heit J, Melton L, Lohse C, Petterson T, Silverstein M, Mohr D, et al. Incidence of venous thromboembolism in hospitalized patients vs community residents. Mayo Clin Proc. 2001;76(11):1102–1110. doi: 10.4065/76.11.1102.
    1. Zhang C, Zhang Z, Mi J, Wang X, Zou Y, Chen X, Nie Z, Luo X, Gan R. The cumulative venous thromboembolism incidence and risk factors in intensive care patients receiving the guideline-recommended thromboprophylaxis. Medicine. 2019;98(23):e15833. doi: 10.1097/MD.0000000000015833.
    1. Anderson F, Zayaruzny M, Heit J, Fidan D, Cohen A. Estimated annual numbers of US acute-care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82(9):777–782. doi: 10.1002/ajh.20983.
    1. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S, Cousin N, Durand A, el Kalioubie A, Favory R, Girardie P, Houard M, Jaillette E, Jourdain M, Ledoux G, Mathieu D, Moreau AS, Niles C, Nseir S, Onimus T, Préau S, Robriquet L, Rouzé A, Simonnet A, Six S, Toussaint A, Dupont A, Bauters A, Zawadzki C, Paris C, Trillot N, Wibaut B, Hochart A, Marichez C, Dalibard V, Vanderziepe S, Bourgeois L, Gaul A, Jospin A, Stepina N, Pradines B, Tournoys A, Brousseau T, Rémy M, Hutt A. Pulmonary embolism in patients with COVID-19. Circulation. 2020;142(2):184–186. doi: 10.1161/CIRCULATIONAHA.120.047430.
    1. Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Pai M, Righini M, Sanfilippo KM, Siegal D, Skara M, Touri K, A. Akl E, Bou Akl I, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Noori A, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Ventresca M, Wiercioch W, Mustafa RA, Schünemann HJ. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021;5(3):872–888. doi: 10.1182/bloodadvances.2020003763.
    1. Feature | Thrombosis and COVID-19: FAQs For Current Practice - American College of Cardiology, editor. American College of Cardiology. 2021.
    1. Information on COVID-19 Treatment, Prevention and Research . COVID-19 Treatment Guidelines. 2021.
    1. Chandra A, Chakraborty U, Ghosh S, Dasgupta S. Anticoagulation in COVID-19: current concepts and controversies. Postgrad Med J. 2021:postgradmedj-2021-139923. 10.1136/postgradmedj-2021-139923.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren